Results for tag: "Remodulin"

Remodulin is a brand of cardiovascular drugs used to treat pulmonary arterial hypertension (PAH). It is a vasodilator, meaning it relaxes the blood vessels, allowing for increased blood flow and improved oxygen delivery to the lungs. Remodulin is administered through an intravenous infusion, and is available in both a short-acting and a long-acting form. The drug is used to reduce symptoms of PAH, such as shortness of breath, fatigue, and chest pain. It can also help improve exercise capacity and quality of life. Remodulin is a relatively new drug, having been approved by the US Food and Drug Administration in 2002. It is currently marketed by United Therapeutics Corporation, and is available in the United States, Canada, and Europe. Other companies involved in the market include Actelion Pharmaceuticals, Bayer, and GlaxoSmithKline. Show Less Read more